Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68071-3874

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-3874). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3874 9)

This is a product description for Atorvastatin Calcium 80mg tablets manufactured by NuCare Pharmaceuticals, Inc. It provides details about the NDC number, expiration date, quantity, active ingredients, and proper storage instructions. The warning advises to keep the product out of reach of children and store it at a controlled temperature of 68-77°F. The text also includes a toll-free number to report any side effects to the FDA.*

FDA Label Image

Atorvastatinfigure1 (Atorvastatinfigure1)

FDA Label Image

Atorvastatintabletsfigure1 (Atorvastatintabletsfigure1)

This is a comparison of cumulative incidence between Atorvastatin and Placebo over a period of 3.5 years. Atorvastatin showed a lower cumulative incidence percentage (4.0%) compared to Placebo. The hazard ratio (HR) was 0.64 with a confidence interval of 0.50-0.83 and a p-value of 0.0005.*

FDA Label Image

Atorvastatintabletsfigure2 (Atorvastatintabletsfigure2)

This text provides information on cumulative hazard percentages for a placebo and Atorvastatin, showing a hazard ratio (HR) of 0.63 with a confidence interval of 0.48-0.83 and a p-value of 0.001. It also includes a chart depicting the time to the first primary endpoint over a four-year follow-up period.*

FDA Label Image

Atorvastatintabletsfigure3 (Atorvastatintabletsfigure3)

This text provides information on the percentage of subjects experiencing an event when taking Atorvastatin at doses of 10mg and 80mg. It also includes data on the Hazard Ratio (HR) and p-value for the comparison. Additionally, it shows the time to the first major cardiovascular endpoint in years.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.